FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes. Grouped from 3 articles across 3 sources.
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.
The US Food and Drug Administration (FDA) is requiring manufacturers of GLP-1 medicines to update their safety labels to warn of a potential increased risk of a rare but serious eye condition that can cause permanent vision loss.
A large study suggests people with type 2 diabetes who start and then stop GLP-1 drugs may have poorer health outcomes, but more research is needed.
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.
Russian Ruble Relaunched Linked to Gold & Commodities Grouped from 2 articles across 1 sources.
"It destroys people, but we all make our own choices" - Marseille drug-gang members spoke to the BBC. Grouped from 2 articles across 1 sources.
Five-times Olympic judo champion Teddy Riner says he is neither leftwing nor rightwing but would seek to ‘bring people together’ The French judo star and five-times Olympic gold medallist Teddy Riner has announced…
Lucy Powell says proposals to end widespread practice will be included in overhaul of England’s national curriculum Pushing GCSE subjects on younger pupils risks turning England’s secondary schools into “early exam…
SoftBank Group announces fiscal second-quarter results for the year ending March 31, 2027.